again, trying to elicit fear by using terminology like crash, fatalist, etc... and trying to put the complete livelihood of the stock down to one aspect (the 10k) that could possibly be negative (even though we all know it doesn't matter all that much for a penny stock and especially a biotech that is relatively young), is not going to work.
Financials mean nothing for Biotechs or penny stocks - go invest in a blue chip Fidelity fund - 90% of stocks in biotech sector have negative eps and here are some to back up the claim:
That is unusually the case when the price is weak going into it. If the price gets weak enough however, it could discount any bad news and we could see a rally in that face of it. That happens a lot.
News 
Market Data 
Discover 
AI
